[
    [
        {
            "time": "2023-10-10",
            "original_text": "大医药细分领域，CXO渐成“时代宠儿”",
            "features": {
                "keywords": [
                    "医药",
                    "CXO",
                    "细分领域",
                    "时代宠儿"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CXO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "大医药细分领域，CXO渐成“时代宠儿”",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "专访王如伟：持续领跑 跨越未来——中国医药创新下半场 商业化是核心竞争力",
            "features": {
                "keywords": [
                    "医药创新",
                    "商业化",
                    "核心竞争力",
                    "王如伟"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "专访王如伟：持续领跑 跨越未来——中国医药创新下半场 商业化是核心竞争力",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "【异动股】泰格医药(03347-HK)涨8.36%",
            "features": {
                "keywords": [
                    "泰格医药",
                    "异动股",
                    "涨8.36%"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【异动股】泰格医药(03347-HK)涨8.36%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 9,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 10,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "爱尔眼科、美年健康、凯莱英、泰格医药、康龙化成等涨超6%",
            "features": {
                "keywords": [
                    "爱尔眼科",
                    "美年健康",
                    "凯莱英",
                    "泰格医药",
                    "康龙化成",
                    "涨超6%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "医疗服务"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "爱尔眼科、美年健康、凯莱英、泰格医药、康龙化成等涨超6%",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "泰格医药大涨5.45%，医疗服务行业涨3.8%",
            "features": {
                "keywords": [
                    "泰格医药",
                    "大涨5.45%",
                    "医疗服务",
                    "行业涨3.8%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "医疗服务"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "泰格医药大涨5.45%，医疗服务行业涨3.8%",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "高瓴资本概念股普遍活跃，凯莱英、泰格医药、公牛集团、国瓷材料等齐涨",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "概念股",
                    "凯莱英",
                    "泰格医药",
                    "公牛集团",
                    "国瓷材料",
                    "齐涨"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "其他行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "高瓴资本概念股普遍活跃，凯莱英、泰格医药、公牛集团、国瓷材料等齐涨",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]